Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Head and Neck Neoplasms | 38 | 2024 | 2923 | 2.380 |
Why?
|
Paranasal Sinus Neoplasms | 13 | 2024 | 243 | 2.270 |
Why?
|
Free Tissue Flaps | 15 | 2024 | 337 | 1.820 |
Why?
|
Carcinoma, Squamous Cell | 32 | 2024 | 4069 | 1.820 |
Why?
|
Skull Base | 5 | 2017 | 294 | 1.620 |
Why?
|
Nose Neoplasms | 8 | 2023 | 250 | 1.330 |
Why?
|
Oropharyngeal Neoplasms | 10 | 2023 | 493 | 1.240 |
Why?
|
Surgical Flaps | 19 | 2021 | 1682 | 1.160 |
Why?
|
Laryngectomy | 7 | 2023 | 245 | 1.030 |
Why?
|
Deglutition Disorders | 3 | 2023 | 641 | 1.020 |
Why?
|
Mouth Neoplasms | 6 | 2023 | 597 | 1.020 |
Why?
|
Parotid Neoplasms | 5 | 2020 | 158 | 0.990 |
Why?
|
Tongue Neoplasms | 4 | 2023 | 186 | 0.930 |
Why?
|
Skull Base Neoplasms | 5 | 2017 | 281 | 0.850 |
Why?
|
Carcinoma, Adenoid Cystic | 9 | 2022 | 264 | 0.800 |
Why?
|
Papillomavirus Infections | 8 | 2023 | 1640 | 0.800 |
Why?
|
Esophageal Stenosis | 1 | 2023 | 197 | 0.790 |
Why?
|
Laryngeal Neoplasms | 6 | 2018 | 515 | 0.770 |
Why?
|
Esthesioneuroblastoma, Olfactory | 5 | 2023 | 58 | 0.760 |
Why?
|
Nasal Cavity | 6 | 2023 | 311 | 0.700 |
Why?
|
Hypopharyngeal Neoplasms | 4 | 2024 | 52 | 0.660 |
Why?
|
Speech Disorders | 2 | 2021 | 180 | 0.630 |
Why?
|
Temporal Bone | 3 | 2014 | 683 | 0.600 |
Why?
|
Glossectomy | 2 | 2023 | 60 | 0.550 |
Why?
|
Lymphatic Metastasis | 4 | 2022 | 2925 | 0.520 |
Why?
|
DNA Helicases | 1 | 2020 | 853 | 0.480 |
Why?
|
Maxillary Sinus Neoplasms | 1 | 2014 | 38 | 0.450 |
Why?
|
Rectus Abdominis | 1 | 2012 | 103 | 0.400 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 5 | 2021 | 326 | 0.400 |
Why?
|
Salivary Ducts | 1 | 2012 | 25 | 0.400 |
Why?
|
Skull Fractures | 1 | 2013 | 203 | 0.390 |
Why?
|
Inappropriate ADH Syndrome | 1 | 2012 | 61 | 0.390 |
Why?
|
Ear Neoplasms | 3 | 2014 | 118 | 0.380 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2020 | 3553 | 0.360 |
Why?
|
Neoplasm Recurrence, Local | 10 | 2024 | 9433 | 0.350 |
Why?
|
Histones | 1 | 2020 | 2592 | 0.340 |
Why?
|
Human papillomavirus 11 | 1 | 2009 | 14 | 0.340 |
Why?
|
Respiratory Tract Neoplasms | 1 | 2009 | 56 | 0.330 |
Why?
|
Neoplasm Invasiveness | 9 | 2023 | 3633 | 0.330 |
Why?
|
Postoperative Complications | 16 | 2024 | 15881 | 0.320 |
Why?
|
Papilloma | 1 | 2009 | 143 | 0.310 |
Why?
|
Salvage Therapy | 5 | 2024 | 1277 | 0.300 |
Why?
|
Carcinoma | 4 | 2015 | 2341 | 0.300 |
Why?
|
Retrospective Studies | 46 | 2024 | 81801 | 0.290 |
Why?
|
Surgical Wound Infection | 5 | 2021 | 1545 | 0.290 |
Why?
|
Parotid Gland | 4 | 2023 | 178 | 0.280 |
Why?
|
Carrier Proteins | 1 | 2020 | 4936 | 0.280 |
Why?
|
Skull Neoplasms | 1 | 2007 | 173 | 0.270 |
Why?
|
Nasal Mucosa | 2 | 2021 | 411 | 0.270 |
Why?
|
Cell Proliferation | 3 | 2020 | 10478 | 0.260 |
Why?
|
Larynx, Artificial | 3 | 2011 | 70 | 0.260 |
Why?
|
Papillomaviridae | 4 | 2022 | 1140 | 0.260 |
Why?
|
Duodenal Neoplasms | 1 | 2006 | 114 | 0.250 |
Why?
|
Humans | 108 | 2024 | 768393 | 0.240 |
Why?
|
Laryngeal Diseases | 2 | 2020 | 248 | 0.240 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 3 | 2020 | 1105 | 0.230 |
Why?
|
Keratins | 1 | 2006 | 502 | 0.230 |
Why?
|
Disease-Free Survival | 9 | 2024 | 6856 | 0.220 |
Why?
|
Neoplasm Staging | 12 | 2023 | 11254 | 0.220 |
Why?
|
Chemokine CXCL9 | 1 | 2023 | 137 | 0.220 |
Why?
|
Thigh | 1 | 2004 | 239 | 0.210 |
Why?
|
Tracheotomy | 2 | 2018 | 168 | 0.210 |
Why?
|
Combined Modality Therapy | 9 | 2021 | 8562 | 0.210 |
Why?
|
Cell Differentiation | 1 | 2020 | 11668 | 0.210 |
Why?
|
Mucins | 1 | 2006 | 571 | 0.200 |
Why?
|
Dilatation | 1 | 2023 | 313 | 0.200 |
Why?
|
Middle Aged | 48 | 2024 | 223491 | 0.190 |
Why?
|
Prosthesis Implantation | 3 | 2011 | 594 | 0.190 |
Why?
|
Antibiotic Prophylaxis | 3 | 2016 | 640 | 0.190 |
Why?
|
Osteopontin | 1 | 2023 | 307 | 0.190 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2002 | 318 | 0.190 |
Why?
|
Adenoma | 1 | 2012 | 2163 | 0.180 |
Why?
|
Male | 59 | 2024 | 364902 | 0.180 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2002 | 361 | 0.180 |
Why?
|
Oral Surgical Procedures | 2 | 2021 | 172 | 0.170 |
Why?
|
Trachea | 3 | 2011 | 1095 | 0.170 |
Why?
|
Female | 57 | 2024 | 397089 | 0.170 |
Why?
|
Cell Polarity | 1 | 2023 | 640 | 0.170 |
Why?
|
Blood Transfusion | 2 | 2018 | 1309 | 0.170 |
Why?
|
Constriction, Pathologic | 1 | 2023 | 1104 | 0.170 |
Why?
|
Parathyroidectomy | 1 | 2002 | 244 | 0.170 |
Why?
|
Treatment Outcome | 22 | 2023 | 65379 | 0.170 |
Why?
|
Immunohistochemistry | 6 | 2019 | 11120 | 0.170 |
Why?
|
Neck | 1 | 2004 | 736 | 0.170 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2009 | 2846 | 0.160 |
Why?
|
Papillomavirus E7 Proteins | 1 | 2019 | 110 | 0.160 |
Why?
|
Alphapapillomavirus | 1 | 2022 | 218 | 0.160 |
Why?
|
Prognosis | 13 | 2023 | 30022 | 0.160 |
Why?
|
Aged | 39 | 2021 | 171562 | 0.160 |
Why?
|
Chemokines, CXC | 1 | 2020 | 420 | 0.160 |
Why?
|
Carcinoma, Mucoepidermoid | 1 | 2019 | 91 | 0.150 |
Why?
|
Head | 1 | 2004 | 927 | 0.150 |
Why?
|
Thyroidectomy | 2 | 2015 | 914 | 0.150 |
Why?
|
Carcinoma, Acinar Cell | 1 | 2018 | 62 | 0.150 |
Why?
|
Nose Deformities, Acquired | 1 | 2018 | 44 | 0.150 |
Why?
|
Radiotherapy, Adjuvant | 5 | 2020 | 1794 | 0.150 |
Why?
|
Epiglottis | 1 | 2017 | 81 | 0.140 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2019 | 755 | 0.140 |
Why?
|
Neck Dissection | 4 | 2023 | 201 | 0.140 |
Why?
|
Neoplasm Metastasis | 5 | 2019 | 4921 | 0.140 |
Why?
|
Laryngoplasty | 1 | 2017 | 53 | 0.140 |
Why?
|
Ear Auricle | 2 | 2014 | 31 | 0.140 |
Why?
|
Scapula | 1 | 2018 | 175 | 0.140 |
Why?
|
Oropharynx | 3 | 2014 | 138 | 0.130 |
Why?
|
Precancerous Conditions | 1 | 2023 | 984 | 0.130 |
Why?
|
Skin Neoplasms | 4 | 2023 | 5857 | 0.130 |
Why?
|
Esthetics | 2 | 2015 | 330 | 0.130 |
Why?
|
Esophagus | 3 | 2011 | 1042 | 0.130 |
Why?
|
Macrophages | 2 | 2023 | 5796 | 0.130 |
Why?
|
Gene Amplification | 1 | 2020 | 1090 | 0.130 |
Why?
|
Skin Transplantation | 2 | 2018 | 1097 | 0.130 |
Why?
|
Arteries | 2 | 2022 | 1126 | 0.120 |
Why?
|
Cervicoplasty | 1 | 2015 | 8 | 0.120 |
Why?
|
Adenocarcinoma | 4 | 2009 | 6406 | 0.120 |
Why?
|
Estrogen Receptor alpha | 1 | 2019 | 581 | 0.120 |
Why?
|
Speech Intelligibility | 1 | 2015 | 80 | 0.120 |
Why?
|
Diagnosis, Differential | 8 | 2020 | 13020 | 0.120 |
Why?
|
Urinary Tract Infections | 1 | 2021 | 806 | 0.120 |
Why?
|
Intraoperative Complications | 1 | 2002 | 1176 | 0.120 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 562 | 0.120 |
Why?
|
Histoplasma | 1 | 2014 | 39 | 0.120 |
Why?
|
Clostridium Infections | 1 | 2021 | 560 | 0.120 |
Why?
|
Receptor, Notch1 | 1 | 2017 | 520 | 0.120 |
Why?
|
Bacteremia | 1 | 2021 | 985 | 0.120 |
Why?
|
Histoplasmosis | 1 | 2014 | 63 | 0.120 |
Why?
|
Endoscopy | 2 | 2015 | 1857 | 0.120 |
Why?
|
Hypersensitivity | 1 | 2024 | 1173 | 0.120 |
Why?
|
Mouth | 1 | 2017 | 383 | 0.120 |
Why?
|
Survival Rate | 9 | 2021 | 12870 | 0.120 |
Why?
|
Tumor Microenvironment | 3 | 2023 | 3939 | 0.110 |
Why?
|
Skull Fracture, Basilar | 1 | 2013 | 6 | 0.110 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2019 | 620 | 0.110 |
Why?
|
Palatine Tonsil | 1 | 2014 | 193 | 0.110 |
Why?
|
Neoplasms, Experimental | 1 | 2019 | 1232 | 0.110 |
Why?
|
Exosomes | 1 | 2018 | 430 | 0.110 |
Why?
|
Postoperative Hemorrhage | 2 | 2015 | 419 | 0.110 |
Why?
|
Frameshift Mutation | 1 | 2015 | 393 | 0.110 |
Why?
|
Colonic Neoplasms | 1 | 2006 | 2544 | 0.110 |
Why?
|
Pharyngeal Diseases | 1 | 2014 | 134 | 0.110 |
Why?
|
Databases, Genetic | 1 | 2020 | 1748 | 0.110 |
Why?
|
Genes, p53 | 1 | 2015 | 716 | 0.110 |
Why?
|
Otolaryngology | 1 | 2020 | 701 | 0.110 |
Why?
|
Pharyngectomy | 3 | 2011 | 45 | 0.110 |
Why?
|
Length of Stay | 6 | 2021 | 6519 | 0.110 |
Why?
|
Fractures, Comminuted | 1 | 2013 | 57 | 0.110 |
Why?
|
Cerebrospinal Fluid Rhinorrhea | 1 | 2013 | 87 | 0.110 |
Why?
|
Mutagenesis, Insertional | 1 | 2015 | 662 | 0.100 |
Why?
|
Papillomavirus Vaccines | 1 | 2019 | 497 | 0.100 |
Why?
|
Gastrostomy | 1 | 2015 | 325 | 0.100 |
Why?
|
Parotid Diseases | 1 | 2012 | 49 | 0.100 |
Why?
|
Lymphocytes | 1 | 2020 | 2611 | 0.100 |
Why?
|
Transferrin | 1 | 2013 | 285 | 0.100 |
Why?
|
Chromatin | 2 | 2022 | 2968 | 0.100 |
Why?
|
Kaplan-Meier Estimate | 4 | 2017 | 6541 | 0.100 |
Why?
|
Sphenoid Sinus | 2 | 2009 | 101 | 0.100 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2020 | 4646 | 0.090 |
Why?
|
Olfactory Mucosa | 1 | 2011 | 101 | 0.090 |
Why?
|
Cell Cycle Proteins | 1 | 2022 | 3458 | 0.090 |
Why?
|
Graft Survival | 4 | 2015 | 3900 | 0.090 |
Why?
|
Parietal Lobe | 1 | 2015 | 866 | 0.090 |
Why?
|
Chordoma | 1 | 2013 | 349 | 0.090 |
Why?
|
Fibula | 2 | 2024 | 270 | 0.090 |
Why?
|
Adult | 22 | 2021 | 223640 | 0.090 |
Why?
|
Pain, Postoperative | 1 | 2020 | 1765 | 0.090 |
Why?
|
Tongue | 2 | 2023 | 406 | 0.090 |
Why?
|
PTEN Phosphohydrolase | 1 | 2015 | 1119 | 0.080 |
Why?
|
Pneumonia | 1 | 2021 | 2163 | 0.080 |
Why?
|
Liposarcoma | 1 | 2012 | 289 | 0.080 |
Why?
|
Negative-Pressure Wound Therapy | 1 | 2011 | 156 | 0.080 |
Why?
|
Optic Disk Drusen | 1 | 2009 | 38 | 0.080 |
Why?
|
Risk Assessment | 5 | 2021 | 24318 | 0.080 |
Why?
|
Reoperation | 3 | 2015 | 4341 | 0.080 |
Why?
|
Hemangiosarcoma | 1 | 2011 | 216 | 0.080 |
Why?
|
Pneumocephalus | 1 | 2008 | 46 | 0.070 |
Why?
|
Quality of Life | 6 | 2024 | 13503 | 0.070 |
Why?
|
Forearm | 2 | 2023 | 428 | 0.070 |
Why?
|
Rhinitis | 1 | 2015 | 751 | 0.070 |
Why?
|
Nuclear Proteins | 1 | 2022 | 5800 | 0.070 |
Why?
|
Aged, 80 and over | 12 | 2021 | 59686 | 0.070 |
Why?
|
Cell Line, Tumor | 2 | 2022 | 17135 | 0.070 |
Why?
|
Gene Expression Profiling | 2 | 2020 | 9510 | 0.070 |
Why?
|
Ear, External | 1 | 2007 | 165 | 0.070 |
Why?
|
Venous Thrombosis | 1 | 2016 | 1317 | 0.070 |
Why?
|
Ear Canal | 1 | 2007 | 149 | 0.070 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 3827 | 0.070 |
Why?
|
Gene Expression | 1 | 2019 | 7598 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3666 | 0.070 |
Why?
|
Transcription, Genetic | 1 | 2020 | 7599 | 0.070 |
Why?
|
Immunity, Innate | 1 | 2018 | 3078 | 0.070 |
Why?
|
Developing Countries | 2 | 2016 | 2903 | 0.070 |
Why?
|
Risk Factors | 10 | 2020 | 74962 | 0.070 |
Why?
|
Keratin-20 | 1 | 2006 | 31 | 0.070 |
Why?
|
Keratin-7 | 1 | 2006 | 55 | 0.070 |
Why?
|
Sinusitis | 1 | 2015 | 995 | 0.070 |
Why?
|
Mucin-2 | 1 | 2006 | 50 | 0.060 |
Why?
|
Carcinoma, Basal Cell | 2 | 2008 | 562 | 0.060 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2019 | 3112 | 0.060 |
Why?
|
Hematocrit | 2 | 2018 | 625 | 0.060 |
Why?
|
Cohort Studies | 6 | 2024 | 41795 | 0.060 |
Why?
|
Ear, Middle | 1 | 2007 | 341 | 0.060 |
Why?
|
RNA, Messenger | 1 | 2020 | 12805 | 0.060 |
Why?
|
Cutaneous Fistula | 2 | 2016 | 79 | 0.060 |
Why?
|
Nose | 2 | 2019 | 523 | 0.060 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2015 | 2952 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 6 | 2013 | 20765 | 0.060 |
Why?
|
Punctures | 3 | 2011 | 372 | 0.060 |
Why?
|
Cheek | 1 | 2004 | 66 | 0.060 |
Why?
|
Follow-Up Studies | 7 | 2015 | 39407 | 0.060 |
Why?
|
Lip Neoplasms | 1 | 2004 | 36 | 0.060 |
Why?
|
Pilot Projects | 3 | 2023 | 8731 | 0.060 |
Why?
|
Analgesics, Opioid | 1 | 2020 | 3836 | 0.060 |
Why?
|
Transcription Factors | 2 | 2022 | 12166 | 0.060 |
Why?
|
Poverty | 1 | 2016 | 2721 | 0.060 |
Why?
|
Survival Analysis | 2 | 2014 | 10117 | 0.060 |
Why?
|
Skull | 1 | 2008 | 831 | 0.060 |
Why?
|
Bacteria | 1 | 2014 | 2221 | 0.050 |
Why?
|
Neoplasm Proteins | 1 | 2015 | 3610 | 0.050 |
Why?
|
Patient Readmission | 1 | 2017 | 3312 | 0.050 |
Why?
|
Postoperative Period | 2 | 2018 | 1830 | 0.050 |
Why?
|
Massachusetts | 4 | 2017 | 8902 | 0.050 |
Why?
|
Lip | 1 | 2004 | 198 | 0.050 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 2 | 2021 | 703 | 0.050 |
Why?
|
Mastoid | 2 | 2014 | 100 | 0.050 |
Why?
|
Melanoma | 1 | 2021 | 5705 | 0.050 |
Why?
|
Xenobiotics | 1 | 2002 | 71 | 0.050 |
Why?
|
Incidence | 6 | 2015 | 21544 | 0.050 |
Why?
|
Face | 1 | 2008 | 1031 | 0.050 |
Why?
|
Salivary Gland Neoplasms | 2 | 2017 | 306 | 0.050 |
Why?
|
Thyroid Neoplasms | 1 | 2015 | 2360 | 0.050 |
Why?
|
Algorithms | 2 | 2015 | 14154 | 0.050 |
Why?
|
Sensation | 1 | 2023 | 337 | 0.050 |
Why?
|
Weight-Bearing | 1 | 2024 | 533 | 0.050 |
Why?
|
Graft Rejection | 1 | 2014 | 4505 | 0.050 |
Why?
|
Curriculum | 1 | 2014 | 3776 | 0.050 |
Why?
|
Hypocalcemia | 1 | 2002 | 203 | 0.040 |
Why?
|
Young Adult | 7 | 2021 | 60049 | 0.040 |
Why?
|
Case-Control Studies | 3 | 2023 | 22296 | 0.040 |
Why?
|
Intubation, Intratracheal | 1 | 2008 | 1359 | 0.040 |
Why?
|
Radius | 1 | 2023 | 443 | 0.040 |
Why?
|
Radiotherapy Dosage | 3 | 2016 | 2922 | 0.040 |
Why?
|
Deglutition | 1 | 2021 | 208 | 0.040 |
Why?
|
Time Factors | 3 | 2021 | 40272 | 0.040 |
Why?
|
Palate, Soft | 1 | 2019 | 100 | 0.040 |
Why?
|
Biopsy, Needle | 1 | 2004 | 1627 | 0.040 |
Why?
|
Poly I-C | 1 | 2019 | 111 | 0.040 |
Why?
|
Neovascularization, Pathologic | 2 | 2015 | 2635 | 0.040 |
Why?
|
Multivariate Analysis | 3 | 2019 | 12092 | 0.040 |
Why?
|
Neoplasm, Residual | 1 | 2024 | 1019 | 0.040 |
Why?
|
Clinical Competence | 1 | 2014 | 4848 | 0.040 |
Why?
|
Radiotherapy | 2 | 2021 | 1509 | 0.040 |
Why?
|
Maxilla | 1 | 2021 | 489 | 0.040 |
Why?
|
Calcinosis | 1 | 2007 | 1481 | 0.040 |
Why?
|
Catheter-Related Infections | 1 | 2021 | 275 | 0.040 |
Why?
|
Palate | 1 | 2018 | 126 | 0.040 |
Why?
|
Injections, Intramuscular | 1 | 2019 | 556 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2015 | 4875 | 0.040 |
Why?
|
Prolapse | 1 | 2017 | 63 | 0.040 |
Why?
|
Dissection | 1 | 2019 | 299 | 0.040 |
Why?
|
Facial Nerve | 1 | 2020 | 277 | 0.040 |
Why?
|
Cicatrix | 1 | 2023 | 799 | 0.040 |
Why?
|
Mutation | 2 | 2023 | 30228 | 0.040 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2018 | 515 | 0.030 |
Why?
|
Clonal Anergy | 1 | 2017 | 169 | 0.030 |
Why?
|
Perception | 1 | 2023 | 1205 | 0.030 |
Why?
|
Positive-Pressure Respiration | 1 | 2021 | 713 | 0.030 |
Why?
|
Oncogenes | 1 | 2022 | 1235 | 0.030 |
Why?
|
Proportional Hazards Models | 3 | 2019 | 12558 | 0.030 |
Why?
|
Sarcoma | 1 | 2008 | 1807 | 0.030 |
Why?
|
Adolescent | 7 | 2017 | 89184 | 0.030 |
Why?
|
Clindamycin | 1 | 2016 | 138 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 4 | 2017 | 36849 | 0.030 |
Why?
|
Facial Paralysis | 1 | 2020 | 346 | 0.030 |
Why?
|
Speech | 1 | 2021 | 558 | 0.030 |
Why?
|
Karnofsky Performance Status | 1 | 2016 | 167 | 0.030 |
Why?
|
Tomography, Optical Coherence | 1 | 2009 | 2957 | 0.030 |
Why?
|
Lymphatic Irradiation | 1 | 2016 | 115 | 0.030 |
Why?
|
Prospective Studies | 4 | 2021 | 54920 | 0.030 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2019 | 1355 | 0.030 |
Why?
|
Vision Disorders | 2 | 2015 | 1093 | 0.030 |
Why?
|
Apoptosis | 2 | 2020 | 9516 | 0.030 |
Why?
|
Pakistan | 1 | 2016 | 298 | 0.030 |
Why?
|
Cadaver | 1 | 2019 | 1366 | 0.030 |
Why?
|
Biopsy, Fine-Needle | 1 | 2020 | 1132 | 0.030 |
Why?
|
Africa, Eastern | 1 | 2014 | 76 | 0.030 |
Why?
|
DNA, Viral | 1 | 2022 | 2205 | 0.030 |
Why?
|
Actinomycosis | 1 | 2014 | 19 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2022 | 2038 | 0.030 |
Why?
|
Endocrinology | 1 | 2020 | 443 | 0.030 |
Why?
|
Relative Biological Effectiveness | 1 | 2016 | 313 | 0.030 |
Why?
|
Kinetics | 1 | 2022 | 6333 | 0.030 |
Why?
|
Neoplasms | 1 | 2023 | 22385 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 2015 | 9198 | 0.030 |
Why?
|
Pseudomonas Infections | 1 | 2018 | 623 | 0.030 |
Why?
|
Aphasia | 1 | 2015 | 193 | 0.030 |
Why?
|
Bangladesh | 1 | 2016 | 741 | 0.030 |
Why?
|
Antigen Presentation | 1 | 2019 | 1251 | 0.030 |
Why?
|
Cleft Palate | 1 | 2019 | 598 | 0.030 |
Why?
|
Ligands | 1 | 2020 | 3283 | 0.030 |
Why?
|
Clavicle | 1 | 2015 | 224 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 2019 | 1561 | 0.030 |
Why?
|
Up-Regulation | 1 | 2002 | 4142 | 0.030 |
Why?
|
Immune Tolerance | 1 | 2002 | 2324 | 0.030 |
Why?
|
Pharyngitis | 1 | 2014 | 222 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2019 | 19022 | 0.030 |
Why?
|
Protons | 2 | 2009 | 1112 | 0.030 |
Why?
|
Sulfonamides | 1 | 2002 | 1980 | 0.030 |
Why?
|
Device Removal | 1 | 2017 | 643 | 0.030 |
Why?
|
Disease Progression | 1 | 2009 | 13646 | 0.020 |
Why?
|
Cancer Vaccines | 1 | 2019 | 1042 | 0.020 |
Why?
|
Bronchoscopy | 1 | 2017 | 913 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2017 | 2524 | 0.020 |
Why?
|
Child | 6 | 2017 | 80891 | 0.020 |
Why?
|
Brain Edema | 1 | 2015 | 607 | 0.020 |
Why?
|
Osteoradionecrosis | 1 | 2011 | 51 | 0.020 |
Why?
|
Craniotomy | 1 | 2015 | 747 | 0.020 |
Why?
|
Health Services | 1 | 2016 | 756 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2019 | 3164 | 0.020 |
Why?
|
Forecasting | 1 | 2020 | 2948 | 0.020 |
Why?
|
Bone Transplantation | 1 | 2015 | 925 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2017 | 2636 | 0.020 |
Why?
|
Cranial Fossa, Anterior | 1 | 2009 | 13 | 0.020 |
Why?
|
Osteotomy | 1 | 2015 | 838 | 0.020 |
Why?
|
Chronic Disease | 2 | 2015 | 9379 | 0.020 |
Why?
|
Texas | 1 | 2011 | 409 | 0.020 |
Why?
|
Nitric Oxide | 1 | 2018 | 2144 | 0.020 |
Why?
|
Biopsy | 2 | 2014 | 6808 | 0.020 |
Why?
|
India | 1 | 2016 | 2325 | 0.020 |
Why?
|
Education, Medical, Continuing | 1 | 2014 | 829 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2017 | 4120 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2016 | 2437 | 0.020 |
Why?
|
Risk | 1 | 2020 | 9636 | 0.020 |
Why?
|
Proteomics | 1 | 2022 | 3906 | 0.020 |
Why?
|
Radiation Injuries | 1 | 2016 | 1204 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2019 | 5496 | 0.020 |
Why?
|
SEER Program | 1 | 2013 | 1474 | 0.020 |
Why?
|
Health Services Needs and Demand | 1 | 2016 | 1407 | 0.020 |
Why?
|
Patient Discharge | 1 | 2021 | 3476 | 0.020 |
Why?
|
Cancer Care Facilities | 1 | 2011 | 424 | 0.020 |
Why?
|
Staphylococcal Infections | 1 | 2016 | 1398 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2014 | 1515 | 0.020 |
Why?
|
Paranasal Sinuses | 1 | 2009 | 266 | 0.020 |
Why?
|
Vaccination | 1 | 2019 | 3431 | 0.020 |
Why?
|
Visual Field Tests | 1 | 2009 | 415 | 0.020 |
Why?
|
Nose Diseases | 1 | 2007 | 79 | 0.020 |
Why?
|
Neutrons | 1 | 2006 | 78 | 0.020 |
Why?
|
Mandible | 1 | 2011 | 759 | 0.020 |
Why?
|
Cranial Fossa, Posterior | 1 | 2006 | 134 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2017 | 2533 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2020 | 3541 | 0.020 |
Why?
|
Cytoskeletal Proteins | 1 | 2011 | 1337 | 0.020 |
Why?
|
Cavernous Sinus | 1 | 2006 | 122 | 0.020 |
Why?
|
Fibroma | 1 | 2007 | 201 | 0.020 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2009 | 342 | 0.020 |
Why?
|
Data Collection | 1 | 2014 | 3324 | 0.020 |
Why?
|
Bone Neoplasms | 1 | 2017 | 2565 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2017 | 3471 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2015 | 2240 | 0.020 |
Why?
|
Quality Assurance, Health Care | 1 | 2015 | 2181 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2017 | 4411 | 0.010 |
Why?
|
Mass Screening | 1 | 2020 | 5451 | 0.010 |
Why?
|
Enteral Nutrition | 1 | 2011 | 804 | 0.010 |
Why?
|
Mice | 2 | 2023 | 82017 | 0.010 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 2006 | 290 | 0.010 |
Why?
|
Prosthesis Failure | 1 | 2009 | 1208 | 0.010 |
Why?
|
Logistic Models | 1 | 2018 | 13323 | 0.010 |
Why?
|
Glycoproteins | 1 | 2011 | 2204 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2016 | 26375 | 0.010 |
Why?
|
Neurons | 1 | 2023 | 9513 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2019 | 8634 | 0.010 |
Why?
|
Carbon | 1 | 2006 | 672 | 0.010 |
Why?
|
Inflammation | 1 | 2002 | 10863 | 0.010 |
Why?
|
Visual Fields | 1 | 2009 | 1067 | 0.010 |
Why?
|
Prosthesis Design | 1 | 2009 | 2126 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2016 | 7861 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2005 | 13697 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15455 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 22355 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2011 | 5313 | 0.010 |
Why?
|
Phenotype | 1 | 2017 | 16721 | 0.010 |
Why?
|
Smoking | 1 | 2016 | 9111 | 0.010 |
Why?
|
Animals | 2 | 2023 | 169337 | 0.010 |
Why?
|
Prevalence | 1 | 2016 | 15872 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2016 | 7463 | 0.010 |
Why?
|
Signal Transduction | 1 | 2019 | 23631 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2009 | 4076 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 18048 | 0.010 |
Why?
|
United States | 2 | 2013 | 73150 | 0.010 |
Why?
|
Infant | 1 | 2015 | 36510 | 0.010 |
Why?
|
Child, Preschool | 1 | 2015 | 42650 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2009 | 9063 | 0.010 |
Why?
|